2nd Quarter - Report — SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY… for SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY… (2015)

Firm

SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS

Client

SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS

Income

—

Expenses

$30,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

SGR Repeal IPAB Repeal PPACA Reform

Lobbyist	Covered position, as disclosed
WAYNE ALAN POWELL	—

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Coverage and Payment for Physician Services

Lobbyist	Covered position, as disclosed
WAYNE ALAN POWELL	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

FDA Device Review Process etc

Lobbyist	Covered position, as disclosed
WAYNE ALAN POWELL	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.